The Administration has proposed a dangerous new policy—known as Most Favored Nation pricing—that will hinder innovators developing cures and our country’s effort to reignite the economy.
This proposal is reckless and particularly right now it is irresponsible as researchers search for treatments and vaccines for COVID-19, which is being led by U.S. industry – the most innovative in the world.
Tell the White House: Keep fighting for cures. Drop the Most Favored Nation pricing proposal now.
Keep Focus on COVID-19 Treatments and Cures
In the middle of a nationwide effort that currently involves nearly 600 clinical trials in communities across all 50 U.S. states and the District of Columbia, U.S. bio-pharmaceutical innovators need to keep their focus on defeating COVID-19.
13 million Americans—one in every 25—are taking part in these trials, sponsored by government and industry and carried out by scientists, doctors, nurses, and caretakers at local universities, hospitals, and clinics in your community and throughout the United States. The approaches they are testing are available due to investments spanning decades.